Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itopride in split-dose PEG bowel preparation
NCT01513096Phase 3Completed
- Sponsor
- Inje University
- Start
- Nov 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of itopride in bowel preparation, sponsored by Inje University. Primary endpoints: Ottawa Bowel Preparation Scale at 3 months and Fluidity Scale at 3 months. Started Nov 2011; status: completed.
02
Drugs
itopride
03
Conditions
bowel preparation
Beyond the preview
Go deeper on NCT01513096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01513096.